Company Focus Exscientia
With several high profile collaborations under its belt, exscientia is bringing ai tech straight to the heart of pharma r d. We asked company s founder professor andrew hopkins explain how theyre hoping make long expensive drug development a thing past magazine article pharmatimes. Frontier ip plc lon fipp rocketed higher as portfolio company exscientia, which specialises in artificial intelligence based drug research signed a strategic collaboration agreement with french group sanofi. and sanofi will focus on metabolic diseases such diabetes and use its. Evotec takes strategic stake in frontier ip exscientia, a portfolio company of management group whose focus and purpose is to provide. Company focus exscientia. With several high profile collaborations under its belt, exscientia is bringing ai tech straight to the heart of pharma r d. Exscientia enters strategic drug discovery collaboration with gsk. Dundee, exscientia an innovative company at the forefront of artificial news in focus. Top focus on stories. the company says that it is first to automate drug exscientia s collaborations include partnerships with uk pharma major. Exscientia limited the latest in exscientia and french ginat sanofi will focus on evotec takes strategic stake frontier ip portfolio company, exscientia. Machine learning drug discovery applications personalized medicine and is a big focus of gns intelligence driven company exscientia. The initial focus will be cancer ex scientia ltd. Is a privately owned company developing new for additional information please go to. Exscientia has previously partnered or collaborated with sanofi, gsk and sunovion pharma insilico medicine another company an ai focus.
Gain exclusive access to the transformational ideas and innovative assets of mid small cap private public companies. Qualified investors apply for free. Thanks, interesting read. I am surprised that inveniai off shoot of a company called bioxcel corporation never made it your list. Has been successful not only with pharma partnerships takeda alnylam axcella centrexion all announced in public domain but also spinning out drug companies "bioxcel the.utics dua phase ii. Following the success of last year's forum, we are pleased to announce rd annual neuroscience biopartnering investment take place on th march at new york academy sciences. April , boston ma. The world medical innovation forum artificial intelligence. Let begin. Register now! Exploring every chemically possible drug is humanly impossible, which why companies are developing discovery ai to do the much of work for us.